Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 1, 2004
Company estimates that its share of the U.S. drug-eluting stent market - as of May 14 - continues to be in excess of 70 percent, on a reorder basis.
-
Apr 30, 2004
A live webcast and replay of the May 6 conference session will be available. Read more.
-
Apr 20, 2004
"This quarter saw the achievement of a major milestone for Boston Scientific with the successful launch of TAXUS in the U.S.," said Jim Tobin, President and CEO.
-
Apr 19, 2004
Combines features from two of Boston Scientific's breakthrough technologies.
-
Apr 14, 2004
Boston Scientific will webcast its conference call with Q1 2004 financial results on Tuesday, April 20. A replay will also be available.
-
Apr 8, 2004
FDA clearance expands Company's family of high-performance self-expanding biliary stents
-
Apr 7, 2004
Acquisition brings high performance medical devices for use in accessing the brain, the heart and other areas of the anatomy. Learn more.
-
Apr 5, 2004
"All aspects of our U.S. TAXUS launch continue to go very well, and we are pleased that we are exceeding expectations," said Jim Tobin, President and Chief Executive Officer.
-
Apr 1, 2004
Company is considering whether to seek damages against Medinol in The Netherlands.
-
Mar 31, 2004
Company has enrolled 1,172 patients, surpassing the required sample size.